Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Non-Muscle Invasive Bladder Neoplasms 1

Interventions

Specimen Handling 40Magnetic Resonance Spectroscopy 28Carboplatin 19Gemcitabine 18Biopsy 17Cyclophosphamide 15fludarabine 14Paclitaxel 14Cisplatin 14pembrolizumab 13Oxaliplatin 12Dexamethasone 12Radiotherapy 11Injections 11Nivolumab 10Interviews as Topic 9venetoclax 8Irinotecan 8Fluorouracil 8Bevacizumab 8X-Rays 7Radiosurgery 7Drug Therapy 7Capecitabine 7Bortezomib 7cemiplimab 6Rituximab 6Pemetrexed 6Doxorubicin 6Calcium Dobesilate 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × pirarubicin × 30 days × Clear all
NCT07424287 2026-06-02

A Study of Intravesical SHR-1501 Combination With BCG Versus Investigator-selected Chemotherapy in Subjects With BCG-unresponsive NMIBC

Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Phase 3 Not yet recruiting
236 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡